OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony

Type:

Video

William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth. Mr. Waddill provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs hearing.

February 5, 2010 Providing Farmers the Tools to Save India's Most Important Export	February 2, 2010 BioBytes: Biotechnology and Vaccines	January 28, 2010 RNAi: Creating a New Approach to Medicine	January 20, 2010 BioBytes: What are biosimilars?
January 12, 2010 BioBytes: Biotechnology and Endangered Animals	December 17, 2009 Drivers Can Find Cellulosic Biofuels for Sale	December 15, 2009 BioBytes: Biotech in the home	December 8, 2009 BioBytes - Biotechnology and food flavoring